Abbvie Inc

NYSE:ABBV   3:47:31 PM EDT
-0.76 (-0.70%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)189.12B
Current PE40.92
Forward PE 8.69
2yr Forward PE 7.92
See more stats
Estimates Current Quarter
Revenue$12.78 Billion
Adjusted EPS$2.80
See more estimates
10-Day MA$107.17
50-Day MA$106.29
200-Day MA$95.63
See more pivots

AbbVie, Inc. Stock, NYSE:ABBV

1 North Waukegan Road, North Chicago, Illinois 60064-6400
United States of America
Phone: +1.847.932.7900
Number of Employees: 47000


AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.